Send me a link:

*Text messaging rates may apply.

 Dow Up 0.47% Nasdaq Up 0.63%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
62.65 1.15(1.87%) Jul 9, 3:59PM EDT
Prev Close:61.50
Open:61.54
Bid:60.01 x 100
Ask:N/A
1y Target Est:85.83
Beta:0.95
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:60.63 - 63.59
52wk Range:36.82 - 80.42
Volume:212,140
Avg Vol (3m):283,333
Market Cap:1.30B
P/E (ttm):107.46
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LGNDUp 1.87%1.30B
LLY67.17B
MRK171.11B
RHHBY253.35B

Key Statistics

Forward P/E (1 yr):24.67
P/S (ttm):23.92
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.44
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.48

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback